Standard Chartered PLC (STAN)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 2,019.00 |
|---|---|
| 52-week range | 1,426.00 – 2,364.00 |
| Return, 1 month / 3 months | −12.7% / −4.8% |
| Return, 1 year / 3 years | +41.4% / +261.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 38 |
| Volatility (1 year) | 30.6% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 11,721.81M GBX |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Standard Chartered PLC is a banking group based in London whose business centres on Asia, Africa and the Middle East. It offers retail banking to individual customers, including current accounts, mortgages and cards, and provides corporate and institutional banking, trade finance, cash management and wealth management to companies, governments and other institutions. Its network spans many emerging markets, and it serves both local customers and international businesses operating across those regions.
Standard Chartered PLC trades under the code STAN on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Standard Chartered PLC (STAN) trades on the London Stock Exchange in UK. It last closed at GBX 2,019.00 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 520 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 41.4% and over the last three months it fell 4.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 68 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 3.5% | ||
| From 52-week high | -13.6% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.8% | ||
| 6-month return | 15.3% | ||
| 12-month return, skipping the last month | 62.0% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 11,721.81M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.8% |
|---|---|
| 1 month | −12.7% |
| 3 months | −4.8% |
| 6 months | +15.3% |
| 1 year | +41.4% |
| 3 years | +261.7% |
| 5 years | +367.3% |
Signals
| 50-day / 200-day average | 2,194.47 / 1,949.79 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 62.65 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.1515 |
| 19 Mar 2026 | GBP 0.3668 |
| 7 Aug 2025 | GBP 0.0918 |
| 27 Mar 2025 | GBP 0.2160 |
| 8 Aug 2024 | GBP 0.0708 |
| 7 Mar 2024 | GBP 0.1677 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.